Capitalizing on transcriptome profiling to optimize and identify targets for promoting early murine folliculogenesis in vitro

Loading...

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

5
views
20
downloads

Citation Stats

Attention Stats

Abstract

jats:titleAbstract</jats:title>jats:pIn vitro ovarian follicle culture is an active area of research towards providing fertility options for survivors of childhood cancer. Late-stage murine follicles (multilayer secondary and onwards) can be cultured successfully to maturity to obtain a meiotically competent oocyte for fertilization, but primordial and primary follicles usually die in culture because many key components of early follicle development are still unknown and difficult to mimic in vitro. To engineer a biomimetic three-dimensional culture system with high efficacy and reproducibility for the clinic, detailed mechanisms of early folliculogenesis must be uncovered. Previous studies have shown that primary murine follicles co-cultured in groups, in contrast to single follicles cultured in isolation, can reach preovulatory size and produce competent oocytes, but the factors accounting for the synergy of follicle co-culture are still unknown. To probe the underlying mechanisms of successful follicle co-culture, we conducted a time-course experiment for murine follicles encapsulated in 0.3% alginate hydrogels and compared between two conditions: groups of 5 (5X) versus groups of 10 (10X). For every 2 days during the course of 12 days, follicles were dissociated and somatic cells were isolated for microarray-based gene expression analysis (n = 380 follicles for 5X and n = 430 follicles for 10X). Gene activities in follicles co-cultured in larger groups (10X) had a distinct transcriptomic profile of key genes and pathways such as prolactin signaling and angiogenesis-related genes when compared to cells from follicles co-cultured in the smaller cohort (5X). To benchmark the results for follicles grown in culture, we compared our microarray data to data from murine follicles freshly isolated from the ovary at comparable stages of development previously published by Bernabé et al. Comparison of these datasets identified similarities and differences between folliculogenesis in the native microenvironment and the engineered in vitro system. A more detailed understanding of follicle growth in vitro will not only allow for better culture methods but also advance the field towards providing improved fertility options for survivors of childhood cancer.</jats:p>

Department

Description

Provenance

Subjects

Citation

Published Version (Please cite this version)

10.1038/s41598-021-92036-y

Publication Info

Jones, Andrea, Beatriz Peñalver Bernabé, Vasantha Padmanabhan, Jun Li and Ariella Shikanov (n.d.). Capitalizing on transcriptome profiling to optimize and identify targets for promoting early murine folliculogenesis in vitro. Scientific Reports, 11(1). 10.1038/s41598-021-92036-y Retrieved from https://hdl.handle.net/10161/33451.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Endorsement

Review

Supplemented By

Referenced By

Scholars@Duke

Jones

Andrea Jones

Postdoctoral Associate

Andrea Jones is a Postdoctoral Associate in Biomedical Engineering at Duke University in the laboratory of Dr. Tatiana Segura. Her research integrates reproductive endocrinology, biomaterials engineering, and neuroscience to understand how dynamic hormonal signaling shapes neural injury, repair, and aging.

 

Andrea earned her Ph.D. in Biomedical Engineering from the University of Michigan, where she trained in biomaterials and regenerative medicine and studied the ovarian microenvironment, fertility preservation, and early-stage follicle development. Her doctoral work was supported by an NIH F31 National Research Service Award (F31 HD106626-01), reflecting early recognition of her potential as an independent investigator. Her scholarship includes first-author publications in Science Advances, Scientific Reports, Current Breast Cancer Reports, and the Journal of Biological Engineering.

 

In the Segura Lab, Andrea investigates sex-specific mechanisms of recovery after ischemic stroke. Her work examines how loss of ovarian hormones influences neuroimmune and neurovascular responses after injury, with the goal of identifying mechanisms that contribute to poorer outcomes with changes in endocrine state. She combines preclinical models of stroke with molecular, cellular, and functional analyses to characterize how hormones shape brain repair.

 

A central focus of Andrea’s research is the development of biomaterial strategies that improve how hormone signals are presented to injured tissue. Rather than relying solely on systemic dosing, she is interested in materials that can control local hormone release, and tissue exposure. Her current work includes engineering biomaterial-based approaches for targeted estrogen receptor agonist delivery to promote recovery after stroke.

 

Andrea has received competitive recognition for her emerging interdisciplinary research, including an American Heart Association Postdoctoral Fellowship, the Duke Institute for Brain Science Germinator Award, and the Gridley McKim-Smith Women’s Health Fellowship. She was selected as a Duke Scholar in Molecular Medicine in the endocrinology track and as a member of the 2025 Leading Edge Fellows cohort. 


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.